implantable pacemakers - search results
If you're not happy with the results, please do another search
MicroPort receives FDA approval for latest range of implantable pacemakers
MicroPort, a global developer in the field of cardiac rhythm management, announced today it has received US Food and Drug Administration (FDA) approval for...
Implantable defibrillators, pacemakers affected by MP3 headphones
Headphones for MP3 players placed within an inch of pacemakers and implantable cardioverter defibrillators may interfere with these devices, according to research presented at the AHA's Scientific Sessions 2008.
EHRA 2023: Electric vehicle chargers found to be safe for patients with pacemakers and...
High power electric vehicle chargers are safe for patients with pacemakers and defibrillators, according to a study published in EP Europace, a journal of...
Medtronic receives CE Mark for Cobalt and Crome implantable ICDs
Medtronic has received CE Mark for its Cobalt and Crome portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy-defibrillators (CRT-D). ICDs monitor heart rhythms...
Cybersecurity safety communications for implantable cardiac devices: Year in review
Cyber security has become a hot topic in recent years. Leslie Saxon writes in Cardiac Rhythm News about the cybersecurity risks for implantable cardiac...
Pacemakers safely reused in Mexico highlight potential of recycling CIEDs
Recycling or reusing cardiac implantable electronic devices (CIEDs) could bring down costs for low-income or uninsured patients. A small study presented at the 30th...
Saving lives with re-used cardiac implantable electronic devices
Behzad Pavri (Thomas Jefferson University Hospital, Philadelphia, USA) is an advocate for re-use of cardiac implantable electronic devices (CIEDs) as life-saving medical technology for...
Pacemakers and other cardiac devices can help solve forensic cases
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at EHRA EUROPACE - CARDIOSTIM 2017. Devices revealed the...
FDA Panel provides recommendations on adverse events, long-term safety and postmarket surveillance of leadless...
The FDA's Circulatory System Devices Panel of the Medical Devices Advisory has made recommendations for leadless pacemakers regarding adverse events, long-term safety issues (including battery longevity), necessary elements for postmarket surveillance, indications for use and labelling, and implanting physicians' training.
Cardiologists expose concerns regarding battery life of cardiac implantable electronic devices
The battery life of cardiac implantable electronic devices must be improved to reduce the need for replacement and the risks this carries for patients, argue UK cardiologists John Dean and Neil Sulke in an editorial published in BMJ.
Biotronik single- and dual-chamber pacemakers and ICDs approved for use in 3 Tesla MRI...
A press release states that the company is now the only one offering both implantable cardioverter-defibrillators (ICDs) and pacemakers approved for 3T scans.
New data show safety and efficacy of specifically designed implantable cardioverter defibrillators for MRI...
Early performance results of the first-in-human international study of Medtronic's Micra Transcatheter Pacing System (TPS) have demonstrated the device is safe and effective.
Biotronik releases new online tool to track MR conditional status of implantable devices
Biotronik has launched ProMRI SystemCheck, a new online tool for tracking the ProMRI status of implantable devices.
Sports for young patients with implantable cardioverter defibrillators: Refining the risk
Elizabeth Saarel (University of Utah, Salt Lake City, USA) argues that, based on prospective registry data, young patients with implantable cardioverter defibrillators can participate safely in competitive sports.
Can heartbeat-induced vibrations be used to power pacemakers?
Piezoelectric harvesters could be used to convert heartbeat-induced vibrations into enough electrical energy to power a cardiac implantable electronic device, according to a preliminary study presented by M Amin Karami, Ann Arbor, USA, at the scientific sessions of the American Heart Association in Los Angeles.
Remote monitoring as safe as standard follow-up in pacemakers
A new study in the European Heart Journal shows that Biotronik's Home Monitoring system is as safe as standard follow-up in patients with pacemakers.
Biotronik launches next-generation programmer for implantable cardiac devices in Japan
Remanic provides an optimised user interface to increase patient's follow-up efficiency as well as a retractable and adjustable touchscreen for optimised viewing and handling.
Medtronic introduces first mobile application for implantable cardiac devices
Medtronic announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. With access to alert transmissions via the CareLink mobile application, health care providers can now manage their patients anytime and anywhere.
Biotronik launches industry’s smallest implantable cardiac device programmer in Europe
Renamic is used for initial programming, reprogramming and testing of implantable pacemakers, implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices after implantation.
ASSERT study demonstrates effectiveness of implantable device monitoring in predicting stroke
Pacemaker patients who have device-detected arrhythmias are approximately 2.5 times more likely to have a stroke than patients who do not have device-detected arrhythmias.
Europace 2009 calls for more remote monitoring of implantable devices
More European countries need to embrace the remote monitoring of cardiac implantable devices, rather than offering face to face clinic visits, concluded a press briefing at Europace 2009.
Medtronic launch newly-FDA approved MyCareLink Smart app-based monitor
According to Medtronic, this is the world's first app-based remote monitoring system for patients with implantable pacemakers.
Biotronik launches new pacing system analyser in Europe
Reliaty is used to ensure adequate lead placement of implantable pacemakers, Implantable Cardioverter-Defibrillators (ICDs) and Cardiac Resynchronisation Therapy (CRT).
MicroPort enters into Series C financing agreements
MicroPort Cardiac Rhythm Management (CRM) has entered into definitive agreements in connection with its Series C financing with total investment proceeds of US$150 million.
Hillhouse...
St Jude Medical announces Merlin cybersecurity updates
St Jude Medical has announced that it will immediately deploy the latest release of cyber security updates for its Merlin remote monitoring system, used...
Mechanical transvenous lead extraction vs. laser lead extraction
Maria Grazia Bongiorni (Pisa, Italy) compares mechanical transvenous lead extraction vs. laser lead extraction approaches with supporting evidence from key randomised controlled trials in...
ESC 2023: Anticoagulation should not be used in patients with AHRE until AF is...
Oral anticoagulation in patients with atrial high rate episodes (AHRE) increases bleeding without reducing a composite outcome of stroke, systemic embolism or cardiovascular death.
This...
US FDA approves Biotronik’s Amvia Edge portfolio
Biotronik has announced US Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge pacemakers and cardiac resynchronisation therapy pacemaker (CRT-P).
In a...
“World’s first” dual chamber leadless pacemaker system granted US FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir dual chamber (DR) leadless pacemaker system, described by the...
HRS 2023: Dynamic monitoring “improves access to care for AF patients”
Findings from a new clinical trial support use of implantable cardiac monitors (ICM) as a standard of care in managing patients with complex cardiac...
Biotronik receives CE mark for Amvia Sky and Edge devices
Biotronik announced today the latest addition to its cardiac rhythm management portfolio.
"We are excited to have received CE mark for our newest technology—the world’s...
Medtronic launches technology aimed at simplifying MRI screening for patients with implanted cardiac devices
Medtronic has announced the launch of MRI Care Pathway, a new system designed to streamline the process of completing magnetic resonance imaging (MRI) scans...
Researchers warn of safety risk to ICDs from mobile devices
Portable electronic devices containing magnets may inhibit pulse generators for implanted cardiac devices (ICDs) and pacemakers according to new research published in Circulation: Arrhythmia...
Philips supports AHA’s CIED infection campaign
Royal Philips is supporting the American Heart Association’s (AHA’S) effort to generate awareness among cross-disciplinary specialties and improve survival rates from cardiovascular implantable electronic...
LifeTech and Medtronic extend HeartTone partnership
LifeTech Scientific Corporation has announced that it has extended its agreements with Medtronic to further the strategic collaboration on the HeartTone domestic pacemaker project...
Study highlights temporal relationship between AF and stroke
Medtronic has announced the publication of a study demonstrating, through the use of a continuous rhythm monitoring device, that atrial fibrillation (AF) is directly...
CERTITUDE registry data shed light on home monitoring of cardiac devices
Biotronik has announced the first observational results of the CERTITUDE registry, documenting real-world clinical outcomes of patients in the USA who use implantable loop...
Use of the antibiotic-eluting envelope in CIEDs: Has it reached prime time?
Bhargav Vemulapalli, Shreya Srivastava and John Kassotis (New Brunswick, USA) review the potential use of antibiotic-eluting envelopes (ABEs) based on available clinical data, while...
New ESC guidelines on cardiac pacing and CRT published
The European Society of Cardiology (ESC) Guidelines on cardiac pacing and cardiac resynchronisation therapy (CRT) have been published online in European Heart Journal.
The use...
FDA issues public warning over interference from consumer electricals on implanted devices
The US Food and Drug Administration (FDA) has issued advice to patients with implanted devices such as pacemakers or implantable defibrillators to take precautions...
Procedural success comparable in CRT implants and upgrades
Rates of procedural success and complications were no different between de novo cardiac resynchronisation therapy (CRT) implantations and upgrades, a study published in JACC:...
MRI scans can be performed safely in non-MR ICDs, study finds
Magnetic resonance imaging (MRI) examinations can be performed safely in patients with non-MR compatible cardiac devices, including those who are pacemaker-dependent or have abandoned...
Mobile phones and smartwatches pose little risk of CIED interference
The risk of electromagnetic interference to cardiovascular implantable electronic devices (CIEDs) from smartwatches and mobile phones is low—although close proximity between an iPhone 6...
Study recommends “widespread adoption” of CVC for CIED implantation
Cephalic vein cutdown (CVC) and axillary vein access (AVA) are both effective approaches for cardiac implantable electronic device (CIED) lead implantation, and could avoid...
PADIT score predicts CIED infection risk
Five independent predictors of cardiac implantable electronic device (CIED) infection have been identified which could be used to aid physicians and patients in decision-making...
Pedro Brugada
With his brothers Josep and Ramon, Pedro Brugada discovered the syndrome that bears their name. He reflects on his career highlights with Cardiac Rhythm...
Confirm Rx ICM allies with SharpSense technology and syncs to a smartphone for a...
Disclaimer: Advertorial sponsored by Abbott
Launched in May 2019 by Abbott, the next-generation Confirm Rx™ insertable cardiac monitor (ICM) has both the CE Mark in...
Cardiac device complications vary widely among hospitals
A study of 174 hospitals in Australia and New Zealand, published recently in the Annals of Internal Medicine, shows that the quality of care...
Low referral rates and treatment disparities lead to underuse of ICDs in indicated patients
Implantable cardiac devices are underused, with widespread gender and race treatment disparities, and low referral rates to electrophysiologists, according to the findings from three...
CRT patients undergoing lead extraction are at no higher risk than non-CRT patients
Transvenous lead extraction in cardiac resynchronisation therapy (CRT) patients is not associated with increased 30-day mortality vs. non-CRT patients. The study found that age,...
Dhanunjaya Lakkireddy
Dhanunjaya Lakkireddy is executive medical director at The Kansas City Heart Rhythm Institute at HCA Midwest Health, Kansas, USA. He holds the title Professor...
Cardiac devices could be at risk of hacking
Medical devices, including cardiovascular implantable electronic devices could be at risk for hacking. In a paper published in the Journal of the American College...
Treating sleep apnoea in pacemaker patients improves AF therapy
This video has been sponsored by LivaNova.
Sleep apnoea is a major chronic disease that can have cardiovascular consequences. Around 40–50% of people with atrial...
Stroke prevention drugs may help reduce dementia risk for atrial fibrillation patients
Patients with atrial fibrillation could reduce the risk of dementia by taking stroke prevention medications, according to recommendations published online in EP Europace1, a...
LivaNova and MicroPort’s Rega family receives regulatory clearance in China
LivaNova and MicroPort’s Shanghai-based joint venture—MicroPort Sorin Cardiac Rhythm Management—has obtained approval for Rega. The family of pacemakers is now approved by the China...
FDA approval for MRI-compatibility for Ellipse ICD
Abbott has received US Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labelling for one of the company’s most widely-used implantable cardioverter...
The impact of the humanitarian EP
Inspired by the 2017 Heart Rhythm Society (HRS) Scientific Sessions opening plenary theme “Becoming a citizen of the world” and the key speaker, Hugh...
Tenth edition of EHRA White Book of cardiac arrhythmia treatment data released
The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017.
The edition marks the ten year anniversary...
Medtronic Reactive ATP therapy slows atrial fibrillation progression in real-world population
Medtronic has announced that its Reactive atrial-based antitachycardia pacing (ATP) therapy slows the progression of atrial fibrillation (AF) in patients with implanted cardiac devices....
Carlos Morillo
Carlos Morillo (Calgary, Canada) was one of the first physicians to document the potential of ablation of the pulmonary vein region as a strategy...
CASE REPORT: WiSE CRT technology ‒ a feasible and effective alternative to conventional CRT
This case report has been written by Timothy Betts (consultant cardiologist and electrophysiologist, Oxford University Hospitals NHS Foundation Trust, Oxford, UK) and has been sponsored by...
Medtronic gets FDA approval for MRI compatible cardiac rhythm and heart failure devices
Medtronic has announced US Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and leads to be...
ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may be on the...
Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...
CorMatrix CanGaroo ECM envelope receives CE mark approval
CorMatrix Cardiovascular has received CE mark approval for its CorMatrix CanGaroo ECM envelope. It is intended for use with cardiac implantable electronic devices including...
New procedure uses heart rate to estimate life expectancy of infarct patients
The heart rate may be an indicator of a person’s life expectancy. A research team at the Technical University of Munich (TUM) (Munich, Germany)...
Rethink of ICD implantation in non-ischaemic heart failure may be on the cards
Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...
Medtronic receives CE mark for three MRI-compatible cardiac resynchronisation therapy defibrillators
The three cardiac resynchronisation therapy defibrillators (CRT-Ds) are approved for 3 Tesla magnetic resonance imaging scans. These devices are the first and only CRT-Ds approved for this level of MRI, according to a company release.
In the absence of testing, ICD optimisation should always be done
Mark W Kroll (Minneapolis, USA) writes about the importance of optimisation of implantable cardioverter defibrillators (ICDs) in the absence of defibrillation threshold testing.
Biotronik Iperia ICD systems with ProMRI technology receive FDA approval
Biotronik has been granted US Food and Drug Administration approval for use of a group of implantable cardioverter defibrillator systems with magnetic resonance imaging scans.
B3 trial to evaluate benefits of unique rate response algorithm for atrial fibrillation patients...
This trial aims to determine if closed loop stimulation can delay the onset of atrial fibrillation and reduce the risk of stroke.
Medtronic announces US launch of Advisa SR MRI SureScan pacing system
The Advisa SR MRI SureScan single-chamber pacemaker with the 5076 MRI lead allows for magnetic resonance imaging (MRI) scans positioned on any region of the body without restrictions.
ESC recommends uninterrupted vitamin K antagonists during ablation and device implantation
The recommendations are an update of EHRA's 2008 consensus document, which required an update due to dramatic changes in the field during the last five years.
Michael Gold
William Gold spoke to Cardiac Rhythm News about his involvement in various clinical trials, his views on the upcoming treatment options for heart failure and the highlights of this year's HRS meeting.
St Jude Medical expands portfolio of MRI-compatible devices to high voltage in Europe
St Jude Medical has received CE mark approval of expanded labelling for its Ellipse implantable cardioverter defibrillator and its Durata and Optisure defibrillation leads. It has received CE mark approval for its Assurity MRI and Endurity MRI pacemaker device families.
Biotronik gets CE mark approval for CardioMessenger Smart device to improve wireless Home Monitoring
New device allows for earlier therapy adjustments in heart patients with pacemakers, implantable cardioverter-defibrillators, cardiac resynchronisation therapy and BioMonitor devices.
Antibacterial envelopes help to reduce infection rates and healthcare costs in high-risk CIED patients
Several recent studies have validated that there is considerable mortality associated from a cardiac implantable electronic device infection in high-risk patients. A strategy using...
CorMatrix CanGaroo ECM Envelope gets approval for South America
CorMatrix announced that it has received international approval from Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) to market the CorMatrix CanGaroo ECM Envelope. canga
Hung-Fat Tse
While Hung-Fat Tse's initial research interests focused on device therapy for cardiac arrhythmias, he has dedicated his career to the development of cardiovascular regenerative medicine.
Medtronic gets FDA approval of pacing lead for full-body MRI scans
Medtronic has announced the US Food and Drug Administration (FDA) approval of its CapSureFix Novus MRI SureScan 5076 lead for use with magnetic resonance imaging (MRI).
Massimo Santini
Massimo Santini performed the first fulguration of the atrioventricular node of resistant supraventricular tachycardia in Italy; he also implanted a pacemaker in the Italian president Carlo Azeglio Ciampi, 10 years ago. Santini speaks to Cardiac Rhythm News about his views on advances in antiarrhythmic drugs, genetics and cardiac arrhythmias, and ECG screening.
FDA clears CorMatrix CanGaroo ECM envelope
CorMatrix Cardiovascular has announced that it has FDA clearance to market the CorMatrix CanGaroo ECM envelope for use with cardiac implantable electronic devices, including pacemakers and implantable cardioverter defibrillators (ICD's).
The incidence of sudden death in heart transplant patients has not improved over the...
A first, large multicentre study in the United States has found that despite the advances in clinical management strategies after heart transplantation, there has not been an improvement in the incidence of sudden cardiac death (SCD) in heart transplant patients over the last three decades.
The role of imaging in the treatment of cardiac arrhythmias
Imaging of the heart has played an important role in defining cardiac structures and characterising the arrhythmic substrates. Among the available imaging modalities, magnetic...
Physicians implant world’s first ProMRI Quadripolar CRT-D system to treat heart failure
With Sentus quadripolar leads and the Inventra series, Biotronik offers the only devices for patients with heart failure worldwide that are approved for MRI use.
First US patients undergo full-body MRI scans with Biotronik DX system technology
Biotronik has announced that the first device patients to undergo full-body magnetic resonance imaging (MRI) scans in the United States have been implanted with the Biotronik DX system.
Leadless pacing: An exciting new technology
By Angela Gonzalez
The concept of a totally self-contained intracardiac pacemaker, first explored over 40 years ago by J W Spickler et al, has finally...
CE mark for Advisa and Ensura SR MRI SureScan pacemaker systems
Medtronic has announced CE mark approval and commercial launch of the Advisa and Ensura SR MRI SureScan single-chamber pacemaker devices in Europe. Both pacemakers are approved for magnetic resonance imaging (MRI) scans positioned on any region of the body.
Richard Fogel
Richard Fogel, president-elect of the Heart Rhythm Society and chief executive officer at St Vincent Medical Group, considers he entered the field of electrophysiology at "the perfect time" when radiofrequency ablation and implantable cardiac defibrillators were emerging as a therapy to treat cardiac rhythm disorders. He spoke with Cardiac Rhythm News about this work, his interests in research and policy and the highlights of this year's Heart Rhythm Society's scientific sessions.
New Heart Rhythm Society Choosing Wisely list details five commonly used treatments and procedures...
The Heart Rhythm Society developed the list as part of Choosing Wisely, an initiative of the American Board of Internal Medicine Foundation launched in 2012 aimed at curbing the use of certain tests and procedures that are not supported by clinical research.
Cardiac resynchronisation therapy with leadless technology is feasible in heart failure patients
Heart failure patients treated in the WISE-CRT study with a leadless ultrasound-based device demonstrated a significant improvement of functional status and a significant increase of left ventricular ejection fraction at six-month follow-up.
First US patient implant with the Nanostim leadless pacemaker
St Jude Medical has announced the first US implant in the company's LEADLESS II pivotal trial designed to evaluate the Nanostim leadless pacemaker for US Food and Drug Administration (FDA) approval.
Antonio Raviele
Antonio Raviele (Venice, Italy), cofounder of the VeniceArrhythmias congress, implanted the first intravenous defibrillator lead in Italy. He spoke to Cardiac Rhythm News about this experience, his current research, his projects dedicated to enhance awareness on cardiac arrhythmias and the highlights of VeniceArrhythmias 2013
FDA Advisory Panel Recommends expanded indication for Medtronic CRT devices in atrioventricular block patients
On 8 October, the FDA's Circulatory Systems Devices Advisory Panel voted that biventricular pacing with Medtronic devices is beneficial for treating patients who have atrioventricular block and left ventricular systolic dysfunction, compared to conventional right ventricular pacing.
TYRX announces first US implantation of AIGISRx R fully bioresorbable antibacterial envelope
TYRX has announced that the first implantation of its new AIGISRx R fully resorbable antibacterial envelope has taken place at the Vanderbilt Heart and Vascular Institute in Nashville, USA, by Christopher R Ellis. The AIGISRx R antibacterial envelope received US Food and Drug Administration (FDA) clearance on 20 May 2013.
ESC and AEPC release consensus statement on paediatric arrhythmias
The consensus on paediatric arrhythmias is the first European statement concerning the diagnosis and management of paediatric arrhythmias. It is also the first joint document between European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) and the Association for European Paediatric and Congenital Cardiology AEPC.
FDA clears fully resorbable AIGISRx R Antibacterial Envelope
AIGISRx R is a fully bioresorbable, antibacterial mesh envelope, intended to hold cardiovascular implantable electronic devices securely in place in order to provide a stable environment when implanted in the body.
First-in-man study shows promise with leadless pacing
At the Heart Rhythm Society (HRS) in Denver, USA, (8-11 May), Vivek Reddy, Mount Sinai School of Medicine, New York, USA, told delegates that leadless right ventricular cardiac pacing is feasible.
Remote monitoring and worldwide adoption: Is it already changing clinical practice?
Thomas Vogtmann reviews expert consensus and guidelines on the adoption of remote monitoring, and discusses how clinical practice might change for the better as a result of its increased usage. He gave this talk at the XV International Symposium on Progress in Clinical Pacing in Rome, Italy
First implantation of AIGISRx R Fully Resorbable Antibacterial Envelope performed in Canada
On 15 April, TYRX announced that the first ever implantation of its new AIGISRx R Fully Resorbable Antibacterial Envelope took place at the Quebec Heart and Lung Institute in Quebec City, Canada by François Philippon.
Leadless technology: the next frontier of cardiac pacing
There are many concerns on leadless technology. However, with the increase recognition of lead related problems and advantages of endocardial pacing, leadless technology will be the next frontier of cardiac pacing. Chu-Pak Lau, Hong Kong, writes for Cardiac Rhythm News.
Weight loss may increase risk of cardiac events in patients implanted with defibrillators
Even minor weight loss is associated with worse health outcomes among patients implanted with cardiac resynchronisation therapy with defibrillator (CRT-D), according to research presented by Valentina Kutyifa, Rochester, USA, at ACC 2013.
New AIGISRx R Fully Resorbable Antibacterial Envelope receives approval from Health Canada
The new envelope includes the advantages of the original AIGISRx, such as stability and implantable electronic devices' infection reduction, but now with the added benefit of being fully resorbable.
Biotronik launches new online Travel Guide for patients with Biotronik cardiac devices
The Travel Guide, which is available in English, German, French, Italian, Dutch, Portuguese and Spanish, gives patients information about recommended hospitals and medical centres in more than 100 countries around the globe.
TYRX receives New Product Innovation Award for antibacterial envelope
The AIGISRx Antibacterial Envelope helps to reduce infection by delivering antibiotics directly to the surgical site in the first 7 to 10 days following implantation of cardiovascular implantable electronic devices.
Chu-Pak Lau
Chu-Pak Lau, honorary clinical professor, Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, talked to Cardiac Rhythm News about rate-responsive pacemakers, the potential role of gene therapy in managing atrial fibrillation, and leadless pacing.
First landmark CIED replacement study of all companies’ cardiac devices provides insight into infection...
The REPLACE study is the first prospective, multicentre trial to examine a broad range of complications related to replacement of all companies' cardiovascular implantable electronic devices (CIED) which includes both pacemakers and ICDs (implantable cardiac defibrillators).
Subclinical atrial tachyarrhythmias, without clinical atrial fibrillation, increase the risk of stroke
A new study, published in the New England Journal of Medicine, has added weight to the view that subclinical atrial fibrillation is a possible cause of cryptogenic stroke after finding that 13% of strokes and systemic embolisms in the study population were associated with subclinical atrial tachyarrhythmias.
MRI may be safe in selected patients with cardiac rhythm management devices
A study published in the Annals of Internal Medicine, the largest published experience of MRI in standard, contemporary cardiac rhythm management devices (CRMDs) to date, shows that MRI can be done safely, with appropriate precautions, in patients with selected cardiac devices.
Quick View report: new addition to Biotronik Home Monitoring
The Quick View report is designed to improve the speed at which clinicians can find and review patient device (pacemaker or implantable cardioverter-defribrillator) data by providing a very intuitive, user-friendly presentation of the information.
Costs, mortality increase following infection in cardiac device recipients
A new US study shows that infections associated with pacemakers and defibrillators led to 4.8 to 7.7-fold increases in admission mortality, 1.6 to 2.1-fold increases long term mortality, 2.5 to 4.0-fold increases in hospital length of stay, and 1.4 to 1.8-fold increases in cost compared to pacemaker and defibrillator implantations without infection.
No interference will occur when headphones are more than two centimetres from a life-saving...
The distance at which headphones cause magnetic interference with active implanted cardiac medical devices (AICMDs), such as implantable cardiac pacemakers (ICPs) and cardioverter defibrillators (ICDs), is less than previously reported, according to a research presented at Heart Rhythm 2011, San Francisco, USA.
Chinese cardiac rhythm management device market forecast to grow to US$650 million by 2015
Greater health care expenditure supported by robust economic growth will lead to nearly 13% annual growth in the market for pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy devices in China, according to Millennium Research Group.
Panos Vardas
Panos Vardas from Greece, president of the European Heart Rhythm Association (EHRA) and president-elect of the European Society of Cardiology (ESC) spoke to Cardiac Rythm News about his passion for Cardiology, his biggest achievements and plans to lead the ESC.
Philips’ new remote pacemaker monitoring designed to improve patient compliance
New 24-hour, web-based service helps cardiologists leverage cutting-edge technology in implanted cardiac devices.
Bruce L Wilkoff
Bruce L Wilkoff, The Cleveland Clinic, Cleveland, USA, has been involved in the development of several cardiac devices. He tells Cardiac Rhythm News which of them he considers the most important.
St Jude Medical announces European launch of USB Cellular adaptor for Merlin@Home Transmitter
New USB adaptor allows patients using Merlin@home transmitter to transfer data to their physician over mobile phone networks.
Boston Scientific to resume distribution of Cognis CRT-Ds and Teligen ICDs in the USA
Boston Scientific has received FDA clearance for the two validated manufacturing changes affecting all of its CRT-Ds and ICDs.
Home monitoring reduces clinic visits and provides rapid detection of events
Data from the studies TRUST; REFORM and ISMOS have demonstrated that the Biotronik Home Monitoring is reliable and effective in managing device patients remotely.
How to improve quality of care in electrophysiology in Europe
Jose L Merino, Hospital Universitario La Paz, Madrid, Spain, analyses the implementation of actions to guarantee quality and qualification in cardiac rhythm management.
Riccardo Cappato
Riccardo Cappato, from Milan, Italy, spoke to Cardiac Rhythm News about his career, advances in cardiac rhythm management, and his passion for crime fiction.
Big disparities in the treatment of arrhythmias across Europe
Latest statistics on pacemakers and implantable cardiac devices were presented at Europace 2009. Germany has one of the highest ICD implant rates in Europe.
UK has its 500,000th pacemaker implanted
The landmark procedure was performed at St George's Hospital, the same London institution that undertook the first implant more than 50 years ago.
John Camm
John Camm talks about his many career achievements including his highlights, research activities and involvement in patient groups.
